Achelios Therapeutics’ lead reformulation product, TOPOFEN™, pairs its proprietary ACHETOGEL™ delivery technology with the proven NSAID ketoprofen. In pre-clinical and early-stage clinical studies, they have shown TOPOFEN™ (ketoprofen) to provide superior tissue penetration compared to other topical formulations currently on the market.

Biotechnology

Achelios Therapeutics

Crist J. Frangakis

John Fort

Wade Ficken

James L. Yeager

Mike S. Fox

The Scientific and Clinical Operations team at Achelios Therapeutics focuses on advancing the development and clinical testing of the company's lead product, TOPOFEN™. This team leverages their expertise to oversee pre-clinical and clinical studies, ensuring robust tissue penetration and effectiveness of TOPOFEN™ while adhering to regulatory standards and scientific rigor.

Scientific and Clinical Operations

About

Team members

Other teams at Achelios Therapeutics

Leadership Team